{"count": 5, "results": [{"_id": "16036498", "pmid": 16036498, "title": "Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy.", "journal": "Blood Press", "authors": ["Olsen MH", "Wachtell K", "Neland K", "Bella JN", "Rokkedal J", "Dige-Petersen H", "Ibsen H"], "date": "2005-01-01T00:00:00Z", "doi": "10.1080/08037050510034185", "meta_date_publication": "2005", "meta_volume": "14", "meta_issue": "3", "meta_pages": "177-83", "score": 50069.348, "text_hl": "@CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@ but not @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ reduce @<m>DISEASE_Carotid_Artery_Diseases</m> @DISEASE_MESH:D002340 @@@carotid artery hypertrophy@@@ in essential @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@. ", "citations": {"NLM": "Olsen MH, Wachtell K, Neland K, Bella JN, Rokkedal J, Dige-Petersen H, Ibsen H. Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy. Blood Press. 2005;14(3):177-83. PMID: 16036498", "BibTeX": "@article{16036498, title={Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy.}, author={Olsen MH and Wachtell K and Neland K and Bella JN and Rokkedal J and Dige-Petersen H and Ibsen H}, journal={Blood Press}, volume={14}, number={3}, pages={177-83}}"}}, {"_id": "15167456", "pmid": 15167456, "title": "Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA).", "journal": "J Hypertens", "authors": ["Zanchetti A", "Bond MG", "Hennig M", "Tang R", "Hollweck R", "Mancia G", "Eckes L", "Micheli D", "ELSA Investigators"], "date": "2004-06-01T00:00:00Z", "doi": "10.1097/00004872-200406000-00022", "meta_date_publication": "2004 Jun", "meta_volume": "22", "meta_issue": "6", "meta_pages": "1201-12", "score": 50048.6, "text_hl": "BACKGROUND: In ELSA, a randomized, double-blind trial in 2334 @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensives@@@, 4-year antihypertensive treatment with @CHEMICAL_lacidipine @CHEMICAL_MESH:C060285 @@@lacidipine@@@ slowed down progression of @<m>DISEASE_Carotid_Artery_Diseases</m> @DISEASE_MESH:D002340 @@@carotid atherosclerosis@@@ significantly more than @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ treatment. ", "citations": {"NLM": "Zanchetti A, Bond MG, Hennig M, Tang R, Hollweck R, Mancia G, Eckes L, Micheli D, ELSA Investigators. Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens. 2004 Jun;22(6):1201-12. PMID: 15167456", "BibTeX": "@article{15167456, title={Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA).}, author={Zanchetti A and Bond MG and Hennig M and Tang R and Hollweck R and Mancia G and Eckes L and Micheli D and ELSA Investigators}, journal={J Hypertens}, volume={22}, number={6}, pages={1201-12}}"}}, {"_id": "8824685", "pmid": 8824685, "title": "Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA).", "journal": "J Hypertens Suppl", "authors": ["Zanchetti A"], "date": "1995-12-01T00:00:00Z", "doi": "10.1097/00004872-199512002-00006", "meta_date_publication": "1995 Dec", "meta_volume": "13", "meta_issue": "4", "meta_pages": "S35-9", "score": 50041.06, "text_hl": "EUROPEAN @CHEMICAL_lacidipine @CHEMICAL_MESH:C060285 @@@LACIDIPINE@@@ STUDY ON @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@ATHEROSCLEROSIS@@@ (ELSA) TRIAL: In the ELSA trial, the effects of @CHEMICAL_lacidipine @CHEMICAL_MESH:C060285 @@@lacidipine@@@-based treatment and beta-blocker (@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@)-based treatment on the development and progression of @<m>DISEASE_Carotid_Artery_Diseases</m> @DISEASE_MESH:D002340 @@@carotid atherosclerosis@@@ are to be assessed in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Zanchetti A. Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens Suppl. 1995 Dec;13(4):S35-9. PMID: 8824685", "BibTeX": "@article{8824685, title={Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA).}, author={Zanchetti A}, journal={J Hypertens Suppl}, volume={13}, number={4}, pages={S35-9}}"}}, {"_id": "30817467", "pmid": 30817467, "title": "Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis.", "journal": "J Hypertens", "authors": ["Bombelli M", "Macchiarulo M", "Facchetti R", "Maggiolini D", "Cuspidi C", "Parati G", "Mancia G", "Grassi G"], "date": "2019-04-01T00:00:00Z", "doi": "10.1097/HJH.0000000000001951", "meta_date_publication": "2019 Apr", "meta_volume": "37", "meta_issue": "4", "meta_pages": "844-850", "score": 50036.55, "text_hl": "METHODS: The European @CHEMICAL_lacidipine @CHEMICAL_MESH:C060285 @@@Lacidipine@@@ Study on @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@Atherosclerosis@@@ (ELSA) was a randomized, double-blind, multicenter trial comparing the effects of a 4-year treatment with either @CHEMICAL_lacidipine @CHEMICAL_MESH:C060285 @@@lacidipine@@@ or @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ on progression of @<m>DISEASE_Carotid_Artery_Diseases</m> @DISEASE_MESH:D002340 @@@carotid atherosclerosis@@@ in @SPECIES_9606 @@@patients@@@ with moderate @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@. ", "citations": {"NLM": "Bombelli M, Macchiarulo M, Facchetti R, Maggiolini D, Cuspidi C, Parati G, Mancia G, Grassi G. Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 2019 Apr;37(4):844-850. PMID: 30817467", "BibTeX": "@article{30817467, title={Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis.}, author={Bombelli M and Macchiarulo M and Facchetti R and Maggiolini D and Cuspidi C and Parati G and Mancia G and Grassi G}, journal={J Hypertens}, volume={37}, number={4}, pages={844-850}}"}}, {"_id": "10694188", "pmid": 10694188, "title": "Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA).", "journal": "J Hypertens", "authors": ["Tang R", "Hennig M", "Thomasson B", "Scherz R", "Ravinetto R", "Catalini R", "Rubba P", "Zanchetti A", "Bond MG"], "date": "2000-02-01T00:00:00Z", "doi": "10.1097/00004872-200018020-00010", "meta_date_publication": "2000 Feb", "meta_volume": "18", "meta_issue": "2", "meta_pages": "197-201", "score": 50035.492, "text_hl": "BACKGROUND AND OBJECTIVE: The European @CHEMICAL_lacidipine @CHEMICAL_MESH:C060285 @@@Lacidipine@@@ Study of @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@Atherosclerosis@@@ (ELSA) is a prospective, randomized, double-blind, multi-national interventional trial to determine the effect of four-year treatment using the @CHEMICAL_Calcium @CHEMICAL_MESH:D002118 @@@calcium@@@ antagonist @CHEMICAL_lacidipine @CHEMICAL_MESH:C060285 @@@lacidipine@@@ versus the beta-blocker @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ on the progression of @<m>DISEASE_Carotid_Artery_Diseases</m> @DISEASE_MESH:D002340 @@@carotid atherosclerosis@@@ in 2259 asymptomatic @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Tang R, Hennig M, Thomasson B, Scherz R, Ravinetto R, Catalini R, Rubba P, Zanchetti A, Bond MG. Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens. 2000 Feb;18(2):197-201. PMID: 10694188", "BibTeX": "@article{10694188, title={Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA).}, author={Tang R and Hennig M and Thomasson B and Scherz R and Ravinetto R and Catalini R and Rubba P and Zanchetti A and Bond MG}, journal={J Hypertens}, volume={18}, number={2}, pages={197-201}}"}}]}